Dr. David Brousseau is the Chair of Pediatrics at Nemours Children’s Health, Delaware, and the Sidney Kimmel Medical College at Thomas Jefferson University. Dr. Brousseau’s academic focus centers on the care of people with sickle cell disease (SCD). He has had continuous federal funding for almost two decades, including sickle cell randomized clinical trials and hybrid-implementation trials. He is currently the study PI on an NHLBI U01 hybrid effectiveness-implementation trial to improve guideline adherence for the care of children presenting to the ED with a painful crisis related to their SCD. He has over 110 publications, including first author publications in JAMA and Blood.